SyntekaBio Inc Working Capital to Net Assets Ratio
SyntekaBio Inc working capital to net assets ratio. SyntekaBio Inc (226330) has a Working Capital to Net Assets ratio of 7.2% as of March 2026. Working capital of ₩2.03 Billion (current assets of ₩14.89 Billion minus current liabilities of ₩12.86 Billion) is measured against net assets of ₩28.34 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of SyntekaBio Inc to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of SyntekaBio Inc (2017–2025)
Working capital to net assets ratio of SyntekaBio Inc from 2017 to 2025. This chart shows how SyntekaBio Inc's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of March 2026, the ratio stands at 7.2%, reflecting working capital of ₩2.03 Billion against net assets of ₩28.34 Billion KRW. See 226330 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
SyntekaBio Inc Working Capital to Net Assets Ratio by Year (2017–2025)
SyntekaBio Inc working capital to net assets ratio by year from 2017 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for SyntekaBio Inc from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see SyntekaBio Inc asset portfolio.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 16.3% | ₩5.19 Billion | ₩31.78 Billion | ₩17.43 Billion | ₩12.24 Billion | ▲ +31.3 pp |
| 2024 | -15.0% | ₩-3.74 Billion | ₩24.94 Billion | ₩12.56 Billion | ₩16.30 Billion | ▼ -23.2 pp |
| 2023 | 8.3% | ₩2.58 Billion | ₩31.23 Billion | ₩21.98 Billion | ₩19.40 Billion | ▼ -40.2 pp |
| 2022 | 48.4% | ₩15.24 Billion | ₩31.46 Billion | ₩37.50 Billion | ₩22.25 Billion | ▼ -155.4 pp |
| 2021 | 203.8% | ₩56.31 Billion | ₩27.63 Billion | ₩58.19 Billion | ₩1.89 Billion | ▲ +106.3 pp |
| 2020 | 97.5% | ₩40.50 Billion | ₩41.54 Billion | ₩41.54 Billion | ₩1.04 Billion | ▲ +0.0 pp |
| 2019 | 97.5% | ₩44.94 Billion | ₩46.11 Billion | ₩45.66 Billion | ₩713.21 Million | ▲ +63.6 pp |
| 2018 | 33.9% | ₩556.20 Million | ₩1.64 Billion | ₩10.54 Billion | ₩9.99 Billion | ▼ -95.9 pp |
| 2017 | 129.7% | ₩-3.62 Billion | ₩-2.79 Billion | ₩1.27 Billion | ₩4.89 Billion | — |